Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NADIR: NeoRecormon in Anemic Patients With Diabetes and CKD
NCT02827266Phase 3Completed
- Sponsor
- Roche
- Start
- Oct 2005
- Primary completion
- Jan 2008
- Modality
- Erythropoietins, Colony Stimulating Factors
- Countries
- 1
01
Overview
A Phase 3 trial of epoetin beta in anemia, sponsored by Roche. Started Oct 2005; status: completed.
02
Drugs
epoetin beta
03
Conditions
anemia
Beyond the preview
Go deeper on NCT02827266.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02827266.